1. Home
  2. INDP vs HTOO Comparison

INDP vs HTOO Comparison

Compare INDP & HTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • HTOO
  • Stock Information
  • Founded
  • INDP 2000
  • HTOO 2020
  • Country
  • INDP United States
  • HTOO Ireland
  • Employees
  • INDP N/A
  • HTOO N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • HTOO Natural Gas Distribution
  • Sector
  • INDP Health Care
  • HTOO Utilities
  • Exchange
  • INDP Nasdaq
  • HTOO Nasdaq
  • Market Cap
  • INDP 7.4M
  • HTOO 6.1M
  • IPO Year
  • INDP N/A
  • HTOO N/A
  • Fundamental
  • Price
  • INDP $0.35
  • HTOO $0.30
  • Analyst Decision
  • INDP Strong Buy
  • HTOO Strong Buy
  • Analyst Count
  • INDP 2
  • HTOO 1
  • Target Price
  • INDP $8.50
  • HTOO $3.50
  • AVG Volume (30 Days)
  • INDP 757.0K
  • HTOO 251.8K
  • Earning Date
  • INDP 05-14-2025
  • HTOO 01-01-0001
  • Dividend Yield
  • INDP N/A
  • HTOO N/A
  • EPS Growth
  • INDP N/A
  • HTOO N/A
  • EPS
  • INDP N/A
  • HTOO N/A
  • Revenue
  • INDP N/A
  • HTOO $1,661,663.00
  • Revenue This Year
  • INDP N/A
  • HTOO $4,832.46
  • Revenue Next Year
  • INDP N/A
  • HTOO $81.82
  • P/E Ratio
  • INDP N/A
  • HTOO N/A
  • Revenue Growth
  • INDP N/A
  • HTOO N/A
  • 52 Week Low
  • INDP $0.31
  • HTOO $0.21
  • 52 Week High
  • INDP $2.89
  • HTOO $1.36
  • Technical
  • Relative Strength Index (RSI)
  • INDP 39.89
  • HTOO 50.12
  • Support Level
  • INDP $0.31
  • HTOO $0.29
  • Resistance Level
  • INDP $0.37
  • HTOO $0.32
  • Average True Range (ATR)
  • INDP 0.04
  • HTOO 0.03
  • MACD
  • INDP 0.00
  • HTOO -0.00
  • Stochastic Oscillator
  • INDP 26.55
  • HTOO 26.64

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About HTOO Fusion Fuel Green PLC

Fusion Fuel Green PLC is a company that has developed a Green Hydrogen production technology. It is focused on generating cost-effective and competitively priced Green Hydrogen.

Share on Social Networks: